iBio, Inc. (62) | Business Operations (9)

Browse by Subcategory

Recent Contracts

Form of Irrevocable Proxy For Voting Control (Filed With SEC on May 12, 2022)
Confidential Settlement and Mutual Release with Fraunhofer USA, Inc. dated May 4, 2021 (Filed With SEC on September 28, 2021)
Collaboration, Option and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
Indemnification Agreement by and between iBio, Inc., John Delta and TechCXO, LLC dated July 13, 2020 (Filed With SEC on October 5, 2020)
Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 19, 2020)
Collaboration and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
Second Amended and Restated Voting Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)
Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)
Form of Indemnification Agreement (Filed With SEC on April 1, 2019)